Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invent Medic publishes newsletter on progress and activities to promote growth in Sweden, Europe and the US

Today, Invent Medic publishes a new issue of the company’s newsletter aimed at shareholders, investors and other interested parties. As the exercise period for the company’s TO 1 subscription warrants is running until March 18, 2021, all shareholders who participated in the 2020 share issue are encouraged to use their warrants in time.In this issue, CEO Karin Bryder talks about progress and new marketing efforts in Sweden, Europe and the US, and the company’s new menstrual cup product ahead of its H2 2021 launch. In Sweden, Invent Medic has signed a new framework agreement for Efemia

IRRAS Announces the recruitment of Sten Gustafsson as Director of Investor Relations

Stockholm, March 9, 2021 - IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, today announced that the hiring of Sten Gustafsson as Director of Investor Relations, reporting directly to the company’s Chief Financial Officer, Sabina Berlin. Sten Gustafsson worked closely with IRRAS for several years as a sell-side analyst at the leading Nordic investment bank ABG and knows the company and sector well. "We have known Sten since 2017 through his previous investment banking experience," said Sabina Berlin. "His thorough

Shape Robotics hires experienced Global Education Director

Rob Widger, former Global Master Trainer at LEGO® Education is now starting his journey as Global Education Director at Shape Robotics.The Danish robotics company Shape Robotics with headquarters in Farum north of Copenhagen as well as an office in Odense, has now brought in Rob Widger from UK as Global Education Director.  Rob Widger has profound experience within the teaching industry and comes directly from a position at Al Ain Education in Dubai where he was responsible for Training & Development. Rob’s passion for hands-on-learning made him write a book on how to implement the use

First European patients dosed in IRLAB’s Phase IIb/III mesdopetam study

IRLAB (Nasdaq Stockholm: IRLAB A) announced today that the first patients in Europe have been dosed in the clinical Phase IIb/III study with mesdopetam. Regulatory authorities across Europe have approved the study and Poland is the first European country where patients have been dosed with mesdopetam.“The Phase IIb/III study is now running on two continents, in the US and Europe. It is great that European sites have now started recruiting and treating patients in this multinational study, maintaining a good recruitment pace. More countries will follow in the coming months,” says Nicholas

ShaMaran January 2021 Payments Received

VANCOUVER, BC – March 9, 2021   ShaMaran Petroleum Corp. (“ShaMaran” or the “Company”) (SNM: TSXV) (SNM: Nasdaq First North Growth Market Sweden) is pleased to confirm payment of $21.7 million ($7.3 million net to the Company) has been received from the Kurdistan Regional Government (“KRG”) for Atrush oil sales invoice entitlements for the month of January 2021.  In addition, the Company has also been paid $1.04 million as the first monthly implementation of the KRG’s proposed repayment mechanism for receivables. OTHER This information is information that ShaMaran is obliged to make

Scandinavian ChemoTech AB (publ) Year-End Report January – December 2020 Executive Summary

Fourth quarter · Net sales amounted to kSEK 0 (72) · Profit before tax amounted to kSEK -2 792 (-4 663) · Earnings per share amounted to SEK -0,46 SEK (-1,37) · Cash flow from operating activities totalled to kSEK -2 794 (-3 159) · The Order book amounted to kSEK 422 at the end of the fourth quarter Period 1 January - 31 December · Net sales amounted to kSEK 131 (484) · Profit before tax amounted to kSEK -8 872 (-7 655) · Earnings per share amounted to SEK -1,95 (-2,35) · Cash flow from operating activities totalled to kSEK -8 701 (-8 066) Important

Ideagen Strengthens Presence in the Global Assurance Sector with the Acquisition of Qualtrax

Leading provider of software for companies operating in highly regulated industries, Ideagen Plc, has today announced the acquisition of US firm Qualtrax.Based in Blacksburg, Virginia, USA, Qualtrax was founded in 1993 and has been named one of Virginia’s top small businesses to work every year since 2018. Qualtrax works with companies to help them meet their assurance obligations and goals through document management, automating key business processes, streamlining training management and ensuring critical industry regulations are met. Qualtrax has around 340 clients, including WalMart,

NoHo Partners’ turnover for February 2021 was approximately MEUR 8.0 and operating cash flow was approximately MEUR -1.7

NoHo Partners PlcSTOCK EXCHANGE RELEASE 9 March 2021 at 9:15 a.m.NoHo Partners’ turnover for February 2021 was approximately MEUR 8.0 and operating cash flow was approximately MEUR -1.7NoHo Partners Plc’s turnover for February 2021 was approximately MEUR 8.0, which is roughly 37 per cent of the turnover for the corresponding period the previous year. The turnover was generated by restaurant operations in Finland, with the restaurants in Denmark and Norway being closed. The Group’s operating cash flow was approximately MEUR -1.7.NoHo Partners CEO Aku Vikström: “The cost savings

The Audiologist Clinic expands with Wallenstam

An increased number of daily spontaneous visits and co-location of premises means that the Audiologist Clinic Gothenburg (Audionommottagning), within the government healthcare agency Habilitation & Health (Habilitering och Hälsa), is increasing its floor space at Södra Gubberogatan 6 in Gothenburg. With an additional rental of just over 400 square meters, the total floor space is increasing to almost 3,300 square meters starting from June 2021.“We are very happy in the premises and with the central, easily accessible location. With increased floor space and the reconstruction, we look

Castellum ready to invest in Stockholm with new office buildings and attractive courtyards

After successful renovation of the historic property on Torsgatan 22-30, Castellum is ready for the next stage in the renewal of the entire block by planning for three office buildings with modern workplaces and activities that attract visitors on evenings and weekends.-Planning process has begun for the investment estimated at approximately SEK 500 million, which would mean that we will have invested close to 2 SEK billion in this fantastic neighborhood. These are strategically sound investments and letting is going well despite the pandemic, says Martin Bjöörn, CEO of Castellum Region

Artificial Solutions announces minor amendments to the terms for convertible notes funding program

Artificial Solutions® International AB (publ) (“Artificial Solutions”) (SSME:ASAI ) has previously announced an agreement with Nice & Green S.A. (“N&G”) regarding a convertible notes funding program. For the purpose of simplifying the administration of the program, Artificial Solutions and N&G have agreed today on certain amendments to the terms of the convertible notes funding program.The amendments imply that the size of each tranche under the program has been increased from SEK 5 million up to SEK 15

Cessatech A/S is awarded Best Medical Treatment IPO Nordics in 2020 by independent editorial

CFI.co - a journal and online resource reporting on business, economics and finance - announced that Cessatech A/S (“Cessatech”) won the 2020 IPO guide for Best Medical Treatment IPO in the Nordics.The CFI.co award selection panel is using a wide range of criteria to help it reach informed decisions regarding the awards, lending the critical eye of a collective 170 years of business journalism, corporate leadership and academia to the exhaustive information gathered by the award body’s own research team. CFI.co have not had a winner of this particular award ‘Best Medical Treatment IPO –

Notice of Annual Shareholders’ Meeting of Dometic Group AB (publ)

The shareholders in Dometic Group AB (publ) (Reg. No. 556829-4390) are hereby summoned to the annual shareholders' meeting on Tuesday, April 13, 2021.Due to the coronavirus, the board of directors has decided that the annual shareholders' meeting will be conducted without the physical presence of shareholders, representatives or third parties and that the shareholders before the meeting will only be able to exercise their voting rights in advance (postal voting). Information on the resolutions passed at the meeting will be disclosed on April 13, 2021, as soon as the outcome of the postal

SciBase announces a Management team change

SciBase’s head of product development, David Melin, has resigned from his position and has accepted a role at another company. The company is reviewing options for the role going forward.  ”I would like to take the opportunity to thank David for his exceptional work at SciBase, and especially his work with our Nevisense hardware platforms. David has managed a very well-functioning development team, and I wish him all the best in his future role”, says Simon Grant CEO SciBase. For more information, please contact:Simon Grant, CEO SciBaseTel: +46 72 887 43 99Email: simon.grant@

NENT Group is launching Viaplay in the Baltics

· Viaplay to offer Baltic viewers a unique combination of Viaplay Originals, international films and series, sports and kids’ content · NENT Group has already before the launch secured exclusive sports rights and distribution deals with local partners · The Viaplay Total package is priced at EUR 9.99 per month and will include film, series and sports Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company, is launching its Viaplay streaming service today in Estonia, Latvia and Lithuania. Viaplay viewers in the Baltics will be able to enjoy a unique

NCC has completed the sale of Valle View in Oslo

NCC has completed the sale of Valle View, the last remaining part of the property development project in the Helsfyr area in Oslo that was sold in August 2019. There will be a positive impact on cashflow in the first quarter 2021 but earnings in the quarter will be impacted by provisions for rental guarantees and VAT.[Valle View Lund Slaatto NCC] Image: Lund & Slaatto Arkitekter In August 2019, NCC sold the development project, consisting of three parts, in the Valle area in Oslo, Norway to a newly formed property company established by Pareto Securities for an underlying property value

NattoPharma ASA is launching cash tender offer to acquire 100% of the shares of Kaydence Pharma AS at an offer price of NOK 5 per share

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Oslo, Norway (9 March 2021) — Reference is made to the stock exchange disclosures by NattoPharma ASA ("NattoPharma") on 15 February 2021 regarding NattoPharma entering into a transaction agreement (the "Transaction Agreement") with Compagnie des Levures Lesaffre ("Lesaffre") under which (i) Lesaffre will launch a recommended voluntary cash tender offer (the "NattoPharma Offer") to acquire 100% of the shares of

NattoPharma ASA: Lesaffre is launching recommended voluntary cash offer for NattoPharma at NOK 35 per share

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Oslo, 9 March 2021: Following the announcement on 15 February 2021 regarding a contemplated offer to acquire all outstanding shares of NattoPharma ASA ("NattoPharma" or the "Company"), Compagnie des Levures Lesaffre ("Lesaffre" or the "Offeror") is today launching a recommended voluntary cash offer (the "Offer") for all of NattoPharma's outstanding shares against a consideration in cash of NOK 35.00 per share (the "

Serneke Group’s Nomination Committee proposes that two new Board members be elected

Ahead of the Annual General Meeting on May 6, 2021, the Nomination Committee of Serneke Group AB (publ) intends to nominate Mariann Östansjö and Lars Kvarnsund as new Board members.Serneke Group’s Nomination Committee intends to nominate Mariann Östansjö, 65 as a new Board member of Serneke Group AB. Mariann has more than 30 years of experience in various roles in financial control and as CFO in privately owned companies, such as Preem and Ragn-Sells, as well as in government-owned companies, such as Green Cargo, and in listed companies, such as Skanska and Eltel. In assignments as CFO,

LMK Group announces its intention to list its shares on Nasdaq First North Premier Growth Market

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES IN ACCORDANCE WITH APPLICABLE LAW. LMK Group AB (publ) ("LMK Group" or the "Company"), operating under four brands; Linas Matkasse (Sweden), Godtlevert and Adams Matkasse (Norway), and RetNemt Måltidskasser (Denmark), today announces

Veriff Appoints Duncan Steblyna as VP of Product to Lead the Company Into Its Next Phase of Rapid Global Growth and Product Innovation

With a decade of product development and strategy experience, he’ll spearhead company efforts to deliver unparalleled identity verification in today’s digital-first worldDuncan Steblyna joins the leading global identity verification (IDV) provider Veriff  as its new VP of Product. Steblyna brings more than a decade of product development and strategy experience to his new role, where he will be leading Veriff's product team through its next phase of rapid growth, meeting the rising demand from customers for reliable identity verification solutions.  “The growing

Wärtsilä’s flexible floating barge-mounted energy storage system will aid a Philippine operator in meeting grid requirements

Wärtsilä Corporation, Press release, 9 March 2021 at 8:00 AM EETThe technology group Wärtsilä’s unique experience in delivering both power barges for electricity production and state-of-the-art energy storage solutions has resulted in a combined contract award. Therma Marine Inc. (TMI), a subsidiary of Aboitiz Power Corporation, one of the Philippines’ leading companies involved in power generation, distribution, and retail electricity services, has ordered a barge-mounted 54 MW / 32 MWh energy storage system to be delivered by Wärtsilä on an engineering, procurement, and construction (EPC)

Storytel strengthens its position in MENA – merges Arabic services

In July 2020, Storytel acquired the Arabic audiobook company Kitab Sawti and initiated a strategic review with the intention of merging the regional Storytel app with Kitab Sawti. Starting today, a joint Kitab Sawti/Storytel team will offer the world’s largest audiobook library in Arabic to subscribers in the MENA region under the consumer brand Storytel.“Storytel and Kitab Sawti have become known as story-focused innovators in the audiobook market in the eyes of both the consumers and publishers in the MENA region. It is truly exciting to merge these two inspiring and leading ‘storytelling

Targovax granted US Patent for ONCOS-102 in combination with checkpoint inhibitors

Extends patent protection of ONCOS-102 in combination with checkpoint inhibitors into the US Oslo, 9 March 2021: Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing oncolytic viruses to target hard-to-treat solid tumors, today announce that the US Patent Office has granted US Patent no 10,940,203. The patent covers the use of ONCOS-102 in combination with checkpoint inhibitors (CPI). Torbjørn Furuseth, Chief Financial Officer of Targovax, said: "We are delighted that this US patent has been granted, further strengthening Targovax's intellectual property

There are no items matching the current filter
There are no more items matching the current filter
Back to top